Filtered By:
Source: Heart Rhythm
Condition: Atrial Fibrillation
This page shows you your search results in order of date. This is page number 10.
Order by Relevance | Date
Total 356 results found since Jan 2013.
B-po03-186 monitoring atrial fibrillation patients using active contactless videoplesthymography implemented on a personal tablet
Early detection of subclinical AF can help prevent significant complications such as embolic stroke, heart failure, and AF-related hospitalizations.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Jean-Philippe Y. Couderc, Gill Tsouri, Celal Savur, John Decamila Xiajuan Xia, Kamil Bukum Betty Mykins, Burr W. Hall Source Type: research
B-po03-156 procedural complications and in-hospital outcomes from left atrial appendage occlusion device implantation in patients with chronic and end stage renal disease
The Watchman device has emerged as an alternative strategy to oral anticoagulation for mitigating ischemic stroke risk in selected patients with atrial fibrillation (AF), but safety data in patients with kidney disease are limited.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Muhammad Bilal Munir, Muhammad Zia Khan, Douglas Darden, Deepak Kumar Pasupula, Sudarshan Balla, Frederick T. Han, Ryan Reeves, Jonathan C. Hsu Source Type: research
B-po03-155 outcomes of left atrial appendage occlusion with watchman in contemporary clinical practice compared with clinical trials: a pooled analysis of protect-af, prevail, and the ncdr laao registry
The PROTECT-AF and PREVAIL trials established Watchman left atrial appendage occlusion (LAAO) as an alternative to warfarin for stroke protection in atrial fibrillation. In clinical practice, LAAO is often performed in patients who cannot tolerate long-term anticoagulation and have more cardiac and non-cardiac comorbidities.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Daniel J. Friedman, Chengan Du, Yongfei Wang Vratika Agarwal, Paul D. Varosy, Frederick A. Masoudi, Jeptha P. Curtis, James Freeman Source Type: research
B-po03-152 left atrial appendage occlusion in patients with intracranial hemorrhage
Patients with prior intracranial hemorrhage (ICH) and atrial fibrillation (AF) are at increased risk of recurrent bleeding; and often not treated with oral anticoagulation despite high risk of ischemic stroke.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Jalaj Garg, Siddharth Shah, Kuldeep Bharat Shah, Mohit K. Turagam, Andrea Natale, Dhanunjaya R. Lakkireddy Source Type: research
B-po03-151 left atrial appendage occlusion as alternative approach for stroke prevention in hereditary hemorrhagic telangiectasia patients with atrial fibrillation
In this study, we evaluate the safety and efficacy of left atrial appendage occlusion (LAAO) for stroke prevention in HHT.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Mohammed Alghammass, Jad Aldanaf, Elizabeth Dranow, Kevin Whitehead Source Type: research
B-po03-148 risk stratification for ischemic stroke and major bleeding in patients without atrial fibrillation - validity of cha2ds2-vasc and has-bled score
Atrial fibrillation (AF) is the most common arrhythmia. Recent cardiac implantable electronic devices (CIEDs) have led to an improvement in the early detection of AF episodes. ESC guidelines for the management of AF recommend the use of CHA2DS2-VASc score as class I to predict the risk of ischemic stroke in patients with AF. However, the validity of the CHA2DS2-VASc and HAS-BLED scores to predict ischemic stroke and major bleeding events in patients without AF remains unclear.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Miyo Nakano, Yusuke Kondo, Masahiro Nakano, Takatsugu Kajiyama, Ryo Ito, Haruhiro Takahira, Mari Kitagawa, Masafumi Sugawara, Toshinori Chiba, Yoshio Kobayashi Source Type: research
B-po04-147 trends in early stroke and mortality in epicardial versus endocardial left atrial appendage closure in atrial fibrillation: nationwide readmissions database 2016-2018
Percutaneous left atrial appendage closure (LAAC) devices have emerged as an important alternative to anticoagulation for stroke prevention in patients with atrial fibrillation. National data on recent trends and early complication rates associated with endocardial (endo) LAAC and epicardial (epi) LAAC procedures are limited.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Edward V. Kogan, Christopher F. Liu, Shing C. Wong, Geoffrey W. Bergman, James E. Ip, George Thomas, Steven M. Markowitz, Bruce B. Lerman, Luke Kim, Jim W. Cheung Source Type: research
B-po04-143 safety and feasibility of reactive atrial-based anti-tachycardia pacing algorithm in cardiovascular implantable electronic devices to suppress atrial fibrillation in patients with left atrial appendage closure device
Reactive atrial-based anti-tachycardia pacing (rATP) in CIED (cardiovascular implantable electronic devices) are effective in AF suppression. Uninterrupted systemic anticoagulation is mandated when these algorithms are activated to avoid stroke and systemic thromboembolism. However, the use of rATP algorithm in patients with left atrial appendage (LAA) closure device without ongoing anticoagulation has not been studied.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Rayan El-Zein, Jordan Luli, Ishmail Saccoh, Cody Carter, Mitchell Stelzer, Emily M. Gates, Zeryab Khan, Ankur N. Shah, James M. Kleman, Sreedhar R. Billakanty, Anish K. Amin, Nagesh Chopra Source Type: research
B-po04-141 left atrial appendage occlusion versus oral anticoagulation as primary strategies to prevent laa thrombus and stroke following left atrial appendage electrical isolation: apropensity score-matched analysis
Left atrial appendage electrical isolation (LAAEI) has been shown to be an effective strategy in catheter ablation (CA) for atrial fibrillation (AF). However, its widespread adaptability is limited because patients must be on lifelong oral anticoagulation (OAC) irrespective of their CHA2DS2VASc score and due to some concerns about increased risk of thromboembolic events (TE) despite OAC.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Jorge Romero, Dhanunjaya R. Lakkireddy, Isabella Alviz, Juan C. Diaz, David F. Briceno, Abhishek Jaiswal, Alejandro Velasco, Carolina R. Valencia, Dalvert Polanco, Daniel Rodriguez, Mohamed Gabr, Joseph Karpenos, Chintan G. Trivedi, Sanghamitra Mohanty, Source Type: research
B-po04-115 hypertension and abnormal renal function increased the risk of ischemic stroke in anticoagulated ehra type-1 valvular atrial fibrillation
Atrial fibrillation (AF) increases the risk of stroke substantially, therefore many scores have been developed to risk stratify these patients. However, most of the previous studies have focused on non-valvular AF. The most widely used risk stratification score is the CHA2DS2-VASC score. Unfortunately, the validation of this score in valvular AF is poor.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Rena Winanti, Sunu Budhi Raharjo, Rina Ariani, Dicky A. Hanafy, Celly Anantaria Atmadikoesoemah, Prima Almazini, Yoga Yuniadi Source Type: research
B-po04-077 heart rate variability and left atrial hemodynamics in atrial fibrillation measured with 4d flow mri
Atrial fibrillation (AF) can lead to stroke due to thrombus formation in the left atrium (LA) or left atrial appendage (LAA). Altered LA hemodynamics in the presence of AF may be predictive of thrombus and stroke risk. Previous 4D flow MRI studies found increased stasis and decreased peak velocity in patients with AF. However, the impact of variable R-R intervals on LA velocity and stasis measurement has not been investigated.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Amanda DiCarlo, Justin Baraboo, Mitchell A. Collins, Maurice Pradella, Patrick M. McCarthy, Philip Greenland, Rishi Arora, Daniel C. Lee, Daniel Kim, Michael Markl, Rod S. Passman Source Type: research
B-po04-053 anticoagulation guided by long-term ecg monitoring using an implantable loop recorder following cryoballoon pulmonary vein isolation in patients with atrial fibrillation
Cryoballoon (CB) pulmonary vein isolation (PVI) is used in patients with atrial fibrillation (AF). Current clinical guidelines recommend continued oral anticoagulation (OAC) in patients (pts) at a high risk of stroke, irrespective of ablation outcome. However, these guidelines do not account for our ability to objectively monitor pts for AF recurrence post-ablation.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Matthew Saberito, Nicolle S. Milstein, Advay G. Bhatt, Mohammadali Habibi, Tina C. Sichrovsky, Mark W. Preminger, Richard E. Shaw, Suneet Mittal, Dan L. Musat Source Type: research
B-po05-059 left atrial appendage occlusion (laao) using watchman device in end stage renal disease: analysis from national inpatient sample
Percutaneous occlusion of left atrial appendage (LAAC) using WATCHMAN device is a widely accepted alternative to oral anticoagulants to prevent ischemic stroke in atrial fibrillation. There is limited data regarding the utilization and safety of this intervention in patients with ESRD.
Source: Heart Rhythm - July 28, 2021 Category: Cardiology Authors: Shakeel Jamal, Ehizogie Edigin, Asim Kichloo, Zulfiqar Qutrio Baloch, Sardar Hassan Ijaz, Abdul Mannan Khan Minhas, Sandeep Banga, Abbas Ali, George Abela Source Type: research
EP News: Clinical
Bernstein et al (JAMA 2021;325:2169–2177; PMID: 34061145) evaluated whether long-term monitoring with an implantable cardiac monitor (ICM) is more effective than usual care for atrial fibrillation (AF) detection in patients with stroke from large- or small-vessel disease. Overall, 242 patients were randomize d to ICM insertion within 10 days of the index stroke. Patients in the control group (n = 250) received site-specific usual care with external cardiac monitoring, such as 12-lead electrocardiograms, Holter monitoring, telemetry, or event recorders.
Source: Heart Rhythm - July 7, 2021 Category: Cardiology Authors: N.A. Mark Estes Tags: EP News Source Type: research
Early recurrence of atrial tachyarrhythmia post-atrial fibrillation ablation: Filling in the blank
Supported by the recent results of the Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation (CABANA) and Early Treatment of Atrial Fibrillation for Stroke Prevention (EAST-AFNET4) trials, catheter ablation is a preferable contemporary linchpin in the treatment of symptomatic atrial fibrillation (AF).1,2 Traditionally, the efficacy with ablation has been broadly defined by either objective arrhythmic recurrence such as atrial arrhythmias of over 30 seconds in duration or subjective recurrence of symptomatic arrhythmias.
Source: Heart Rhythm - June 29, 2021 Category: Cardiology Authors: Christopher A. Groh, T. Jared Bunch Source Type: research
